CAPTRUST Financial Advisors’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-67,877
Closed -$2.01M 2735
2023
Q4
$2.01M Sell
67,877
-28,501
-30% -$568K 0.01% 904
2023
Q3
$1.53M Buy
96,378
+35,011
+57% +$582K 0.01% 974
2023
Q2
$1.16M Buy
61,367
+34,482
+128% +$407K ﹤0.01% 1117
2023
Q1
$103K Sell
26,885
-423
-2% -$1.8K ﹤0.01% 2155
2022
Q4
$135K Buy
+27,308
New +$148K ﹤0.01% 2014
2022
Q3
Sell
-2,016
Closed -$9K 4343
2022
Q2
$9K Hold
2,016
﹤0.01% 3829
2022
Q1
$10K Hold
2,016
﹤0.01% 3822
2021
Q4
$15K Buy
2,016
+148
+8% +$920 ﹤0.01% 3492
2021
Q3
$11K Buy
1,868
+1,122
+150% +$6.48K ﹤0.01% 3574
2021
Q2
$5K Hold
746
﹤0.01% 3887
2021
Q1
$6K Buy
746
+498
+201% +$4.07K ﹤0.01% 3681
2020
Q4
$2K Sell
248
-300
-55% -$1.75K ﹤0.01% 3177
2020
Q3
$2K Hold
548
﹤0.01% 2829
2020
Q2
$3K Buy
+548
New +$2.33K ﹤0.01% 2538
2019
Q4
Sell
-448
Closed -$1K 1895
2019
Q3
$1K Hold
448
﹤0.01% 1890
2019
Q2
$1K Buy
448
+108
+32% +$255 ﹤0.01% 1886
2019
Q1
$1K Buy
+340
New +$1.47K ﹤0.01% 1773
2018
Q1
Sell
-67
Closed 1395
2017
Q4
$0 Buy
+67
New +$413 ﹤0.01% 1282

Other funds holding IMGN

CAPTRUST Financial Advisors's IMGN Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 67,877 shares — an estimated $2.01M sold.

CAPTRUST Financial Advisors first reported a position in IMGN in Q4 2017 and held it in 18 quarters. The position peaked at $2.01M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • CAPTRUST Financial Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 67,877 Immunogen Inc shares in Q1 2024, an estimated $2.01M.
  • CAPTRUST Financial Advisors first reported a position in Immunogen Inc in Q4 2017 and held it in 18 quarters.
  • CAPTRUST Financial Advisors's Immunogen Inc position peaked at $2.01M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.